tiprankstipranks
NurExone Biologic (DE:J90)
FRANKFURT:J90
Germany Market
J90
NurExone Biologic
RESEARCH TOOLSreports

NurExone Biologic (J90) Stock Forecast & Price Target

4 Followers
See the Price Targets and Ratings of:

J90 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
NurExone
Biologic
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

J90 Stock 12 Month Forecast

There Are No Analyst Ratings for DE:J90 In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

J90 Financial Forecast

J90 Earnings Forecast

Next quarter’s earnings estimate for J90 is -€0.02 with a range of -€0.02 to -€0.02. The previous quarter’s EPS was ―. J90 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year J90 has Performed in-line its overall industry.
Next quarter’s earnings estimate for J90 is -€0.02 with a range of -€0.02 to -€0.02. The previous quarter’s EPS was ―. J90 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year J90 has Performed in-line its overall industry.
No data currently available

J90 Sales Forecast

Next quarter’s sales forecast for J90 is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were ―. J90 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year J90 has Performed in-line its overall industry.
Next quarter’s sales forecast for J90 is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were ―. J90 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year J90 has Performed in-line its overall industry.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering NurExone Biologic

3 Months
Siddharth RajeevFundamental Research
Success Rate
0/0 ratings generated profit
Average Return
-
Copying Siddharth Rajeev's trades and holding each position for 3 Months would result in - of your transactions generating a profit, with an average return of - per trade.
1 Year
Siddharth RajeevFundamental Research
Success Rate
0/0 ratings generated profit
Average Return
-
Copying Siddharth Rajeev's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of - per trade.
2 Years
Siddharth RajeevFundamental Research
Success Rate
0/0 ratings generated profit
Average Return
-
Copying Siddharth Rajeev's trades and holding each position for 2 Years would result in - of your transactions generating a profit, with an average return of - per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

J90 Analyst Recommendation Trends

Rating
Dec 24
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
total
1
In the current month, J90 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. J90 average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

J90 Stock Forecast FAQ

What is DE:J90’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:J90’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:J90, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is NurExone Biologic a Buy, Sell or Hold?
      Currently, no data Available
      What is NurExone Biologic’s share price target?
      Currently, no data Available
      What do analysts say about NurExone Biologic?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of NurExone Biologic?
      To buy shares of DE:J90, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.